A detailed history of State Of Michigan Retirement System transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, State Of Michigan Retirement System holds 4,767,133 shares of BMY stock, worth $232 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares
4,767,133
Previous 1,924,733 147.68%
Holding current value
$232 Million
Previous $104 Million 89.68%
% of portfolio
1.03%
Previous 0.57%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$40.25 - $52.99 $114 Million - $151 Million
2,842,400 Added 147.68%
4,767,133 $198 Million
Q1 2024

Apr 18, 2024

BUY
$47.98 - $54.4 $62.4 Million - $70.7 Million
1,300,400 Added 208.29%
1,924,733 $104 Million
Q4 2023

Jan 22, 2024

SELL
$48.48 - $57.85 $34.4 Million - $41 Million
-709,100 Reduced 53.18%
624,333 $32 Million
Q3 2023

Oct 27, 2023

BUY
$57.89 - $64.73 $7.74 Million - $8.65 Million
133,700 Added 11.14%
1,333,433 $77.4 Million
Q2 2023

Jul 26, 2023

SELL
$63.71 - $70.74 $1.22 Million - $1.36 Million
-19,200 Reduced 1.58%
1,199,733 $76.7 Million
Q1 2023

Apr 28, 2023

BUY
$65.71 - $74.53 $400,830 - $454,633
6,100 Added 0.5%
1,218,933 $84.5 Million
Q4 2022

Jan 27, 2023

SELL
$68.48 - $81.09 $212,288 - $251,379
-3,100 Reduced 0.25%
1,212,833 $0
Q3 2022

Oct 24, 2022

BUY
$0.13 - $76.84 $6,955 - $4.11 Million
53,500 Added 4.6%
1,215,933 $86.4 Million
Q2 2022

Aug 08, 2022

SELL
$72.62 - $79.98 $233 Million - $256 Million
-3,203,000 Reduced 73.37%
1,162,433 $89.5 Million
Q1 2022

May 04, 2022

SELL
$61.48 - $73.72 $100 Million - $120 Million
-1,629,034 Reduced 27.18%
4,365,433 $319 Million
Q4 2021

Jan 27, 2022

BUY
$53.63 - $62.52 $33.7 Million - $39.3 Million
627,924 Added 11.7%
5,994,467 $374 Million
Q3 2021

Oct 27, 2021

BUY
$59.17 - $69.31 $83.2 Million - $97.4 Million
1,405,700 Added 35.49%
5,366,543 $318 Million
Q2 2021

Jul 27, 2021

BUY
$61.91 - $67.42 $4.13 Million - $4.5 Million
66,700 Added 1.71%
3,960,843 $265 Million
Q1 2021

May 03, 2021

BUY
$59.34 - $66.74 $95.1 Million - $107 Million
1,603,100 Added 69.97%
3,894,143 $246 Million
Q4 2020

Feb 01, 2021

BUY
$57.74 - $65.43 $98 Million - $111 Million
1,697,200 Added 285.8%
2,291,043 $142 Million
Q3 2020

Oct 26, 2020

BUY
$57.43 - $63.64 $918,880 - $1.02 Million
16,000 Added 2.77%
593,843 $35.8 Million
Q2 2020

Jul 29, 2020

BUY
$54.82 - $64.09 $2.22 Million - $2.59 Million
40,474 Added 7.53%
577,843 $34 Million
Q1 2020

May 01, 2020

BUY
$46.4 - $67.43 $23.5 Million - $34.2 Million
507,416 Added 1694.04%
537,369 $30 Million
Q1 2020

Apr 28, 2020

SELL
$46.4 - $67.43 $24.9 Million - $36.2 Million
-537,016 Reduced 94.72%
29,953 $1.67 Million
Q4 2019

Jan 24, 2020

BUY
$49.21 - $64.19 $8.55 Million - $11.2 Million
173,752 Added 44.19%
566,969 $36.4 Million
Q3 2019

Oct 22, 2019

BUY
$42.77 - $50.71 $68,432 - $81,136
1,600 Added 0.41%
393,217 $19.9 Million
Q2 2019

Jul 26, 2019

SELL
$44.62 - $49.34 $3.52 Million - $3.89 Million
-78,900 Reduced 16.77%
391,617 $17.8 Million
Q1 2019

May 06, 2019

BUY
$45.12 - $53.8 $144,384 - $172,160
3,200 Added 0.68%
470,517 $22.4 Million
Q4 2018

Feb 01, 2019

SELL
$48.76 - $63.23 $13.9 Million - $18.1 Million
-285,600 Reduced 37.93%
467,317 $24.3 Million
Q3 2018

Oct 26, 2018

BUY
$55.19 - $62.25 $126,937 - $143,175
2,300 Added 0.31%
752,917 $46.7 Million
Q2 2018

Aug 08, 2018

BUY
$50.53 - $62.98 $166,749 - $207,834
3,300 Added 0.44%
750,617 $41.5 Million
Q1 2018

May 08, 2018

BUY
$59.92 - $68.98 $47,936 - $55,184
800 Added 0.11%
747,317 $47.3 Million
Q4 2017

Feb 01, 2018

SELL
$59.94 - $65.35 $1.07 Million - $1.16 Million
-17,800 Reduced 2.33%
746,517 $45.7 Million
Q3 2017

Oct 19, 2017

BUY
$55.23 - $63.74 $42.2 Million - $48.7 Million
764,317
764,317 $48.7 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $104B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track State Of Michigan Retirement System Portfolio

Follow State Of Michigan Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Michigan Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Of Michigan Retirement System with notifications on news.